- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Empagliflozin; 2. empagliflozin with metformin; 3. linagliptin; 4. linagliptin with metformin – November 2017
Empagliflozin, 2. Empagliflozin with metformin, 3. Linagliptin, 4. Linagliptin with metformin: 1. Ta
Last updated
2 March 2018